HRMY NASDAQ
Harmony Biosciences Holdings, Inc.
1W: +7.5%
1M: +5.5%
3M: +16.9%
YTD: -3.7%
1Y: -1.9%
3Y: +3.0%
5Y: +30.1%
$35.77
-0.24 (-0.67%)
Weekly Expected Move ±7.8%
$30
$33
$35
$38
$41
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.1B
52W Range25.52-40.87
Volume882,096
Avg Volume826,567
Beta0.94
Dividend—
Analyst Ratings
Company Info
CEOJeffrey Dayno
Employees293
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-19
Websiteharmonybiosciences.com
630 West Germantown Pike
Plymouth Meeting, PA 19462
US
Plymouth Meeting, PA 19462
US
484 539 9800
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
Latest News
5 Undervalued Price-to-Book Stocks Worth Adding to Your Portfolio
Alkermes Q2 Earnings Break Even, Revenues Beat Estimates, Stock Down
Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings Growth
Will REGN's Q2 Earnings Get a Boost From Dupixent and Eylea HD?
The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Mollichella Stephen | 0 | — | 2026-07-16 | |
| Mollichella Stephen | 12,172 | $37.46 | 2026-07-16 | |
| Mollichella Stephen | 8,500 | $30.69 | 2026-07-16 | |
| Mollichella Stephen | 7,050 | $38.01 | 2026-07-16 | |
| Mollichella Stephen | 20,750 | $36.76 | 2026-07-16 |